ESR1 and breast cancer: In the only prior study on androgens in pregnancy and breast cancer risk, in the FMC [9], testosterone was positively associated with risk of ER–/PR– tumors in the subgroups of women diagnosed younger than age 40 or with first birth younger than age 30; testosterone was not associated with breast cancer overall or in the ER+/PR+ subgroup.